NEW ENTERPRISE ASSOCIATES 13 LP 13D/13G Filings for PhaseBio Pharmaceuticals, Inc. (PHASQ)

NEW ENTERPRISE ASSOCIATES 13 LP 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-11-04
4:42 pm
Sale
2022-11-0313DPhaseBio Pharmaceuticals, Inc.
PHASQ
NEW ENTERPRISE ASSOCIATES 13 LP0
0.000%
-6,641,634decrease
(Position Closed)
Filing